Health Insurance
Health insurance news and analysis, with coverage of general health insurance trends, major medical insurance, disability insurance, dental insurance, vision plans, telemedicine plans, critical illness insurance, hospital indemnity insurance, short-term health insurance, the Affordable Care Act public exchange program, and more.
PPACA: NAIC Task Force OKs Model
By Staff WriterThe Regulatory Framework Task Force at the National Association of Insurance Commissioners has endorsed a preexisting conditions exclusions model.
November 22, 2010
CBO Analyzes Medicare ProposalCongressional Budget Office analysts say the Rivlin-Ryan Medicare proposal could lead to a reduction in federal outlays.
November 22, 2010
PPACA: Minimum MLR Regs Leave Wiggle Room for Mini Meds, CommissionsThe U.S. Department of Health and Human Services is adopting most of the minimum medical loss ratio guidelines draft that was approved by the National Association of Insurance Commissioners Oct. 21.
November 22, 2010
Medicare panel recommends prostate drugThe Medicare panel charged with recommending which drugs the government health program should cover has approved Dendreon Corporation's prostate cancer drug, Provenge.
November 22, 2010
U.S. Health Care is Expensive - but There are Some Bargains...Value hunters should skip angioplasties in the United States and go for the cataract surgery instead.
November 22, 2010
PPACA: NAHU to Continue MLR Commission Pass-Through FightThe National Association of Health Underwriters will be asking Congress to change the medical loss ratio formula in the interim regulations released Monday by the U.S. Department of Health and Human Services.
November 22, 2010
Commission ponders Medicare paradigm shiftThe presidential deficit commission is debating whether to shift Medicare from a government-paid plan to one in which seniors are issued vouchers to pay for private health insurance.
November 22, 2010
Medicare panel recommends prostate drugThe Medicare panel charged with recommending which drugs the government health program should cover has approved Dendreon Corporation's prostate cancer drug, Provenge.